Catalyst Wire Dossier Catalyst Wire Dossier

Integrilin (eptifibatide)

eptifibatide · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Integrilin (eptifibatide), covering 2015-11-25 to 2015-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR) [Phase 2]

See pricing